Rheumatology
Conference Coverage
Sex differences seen in inflammatory arthritis health care use
Women’s higher risk of conditions such as osteoarthritis and pain and fatigue may help to explain why overall healthcare resource use was higher...
Conference Coverage
Severe COVID-19–related outcomes found worse in men with RA
A retrospective study of patients with rheumatoid arthritis and COVID-19 showed that men had more baseline comorbidities and increased risk of...
Conference Coverage
New ESC guidelines for cutting CV risk in noncardiac surgery
The guidelines, which aim to reduce cardiovascular complications from noncardiac surgery, introduce new concepts and recommendations, compared...
Conference Coverage
Hip fractures likely to double by 2050 as population ages
Greater efforts “are needed to prevent hip fractures and improve the treatment gap and post-fracture care, especially in men and the oldest old...
News
Autoimmune disease patients’ waxing, waning response to COVID vaccination studied in-depth
Patients with immune-mediated inflammatory diseases have weaker vaccine-induced immunity to COVID but are able to build a humoral immune response...
Conference Coverage
Rivaroxaban outmatched by VKAs for AFib in rheumatic heart disease
A striking and unexpected reduction in death with the use of predominantly warfarin was just one of the many surprises delivered by the INVICTUS...
Conference Coverage
Vitamin D supplements do not lower risk of fractures
“I would use markers of bone formation as a better measure to determine whether they need vitamin D or not, specifically looking at parathyroid...
News
Methotrexate’s impact on COVID-19 vaccination: New insights made
New studies assess patients with various immune-mediated inflammatory diseases to determine the risks and benefits of pausing methotrexate after...
News
Add AFib to noncardiac surgery risk evaluation: New support
Preexisting atrial fibrillation should again be part of pre–noncardiac surgery cardiac risk assessment, argues a new report.
Conference Coverage
Immunosuppressed rheumatic patients not at high risk of breakthrough COVID-19
Patients with immunomodulated inflammatory diseases are not an at-risk group for breakthrough COVID-19 infections, apart from those on anti-CD20...